Skip to main
GRDN

GRDN Stock Forecast & Price Target

GRDN Analyst Ratings

Based on 5 analyst ratings
Strong Buy
Strong Buy 60%
Buy 40%
Hold 0%
Sell 0%
Strong Sell 0%

Bulls say

Guardian Pharmacy Service is a leading provider in the long-term care pharmacy industry, with a strong focus on technology-enabled services that improve clinical outcomes and reduce costs for residents of assisted living facilities and other long-term care facilities. The company's strong financial flexibility, ongoing growth through M&A and greenfield expansions, and a robust suite of technology assets differentiate it in the fragmented market. Despite potential risks such as regulatory changes and supply chain disruption, we believe Guardian Pharmacy Service's strong positioning and growth opportunities make it a sound investment.

Bears say

Guardian Pharmacy Service is facing strong competition in its market and has been relying on non-sustainable drivers, such as favorable payor settlements and M&A integration, for its recent earnings beat. The company also faces potential revenue impact due to the IRA, and its market share is only at 13%. Additionally, the company's reliance on pharmaceutical and medical product sales may be a risk in the long-term.

GRDN has been analyzed by 5 analysts, with a consensus rating of Strong Buy. 60% of analysts recommend a Strong Buy, 40% recommend Buy, 0% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Guardian Pharmacy Services Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Guardian Pharmacy Services Inc (GRDN) Forecast

Analysts have given GRDN a Strong Buy based on their latest research and market trends.

According to 5 analysts, GRDN has a Strong Buy consensus rating as of Aug 25, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $44.60, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $44.60, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Guardian Pharmacy Services Inc (GRDN)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.